- জেনেরিক নাম
- Ticagrelor
- শক্তি
- 90 mg
- ডোজ ফর্ম
- Tablet
- প্রস্তুতকারক
- The ACME Laboratories Ltd.
Ticaflow 90 Tablet
Ticaflow 90 Tablet সম্পর্কে
বাংলাদেশে Ticaflow 90 Tablet ট্যাবলেট হিসেবে পাওয়া যায়; এতে Ticagrelor আছে (৯০ mg)। Ticaflow 90 প্রস্তুত করেছে The ACME Laboratories Ltd। Ticaflow 90-এর সাথে Ticagrelor-এর অন্য ব্র্যান্ডের দাম নিচে তুলনা করে দেখুন। ডাক্তারের প্রেসক্রিপশন মেনে চলুন এবং অন্য ব্র্যান্ড খাওয়া যাবে কি না তা ফার্মাসিস্টের কাছ থেকে জেনে নিন।
Ticagrelor-এর ১৩টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। সবচেয়ে কম দাম Belinta 60 mg Tablet-এর, প্রতি ইউনিট ৳ ৩৫.০০।
Ticaflow 90 Tablet কী?
Ticaflow 90 90 mg is a tablet product of The ACME Laboratories Ltd. that contains Ticagrelor. Its active ingredient is Ticagrelor, which belongs to a group of medicines called anti-platelet drugs. It is prescribed for adults who have had an acute coronary syndrome, such as unstable angina or a heart attack, including those treated with medicines alone or with procedures like angioplasty or bypass surgery. Use it only as your doctor directs.
Ticaflow 90-এর ব্যবহার
Ticaflow 90 is used in adults to help prevent atherothrombotic events after an acute coronary syndrome. It is prescribed whether the patient is managed with medicines alone or with procedures such as percutaneous coronary intervention or coronary artery bypass grafting. It is taken alongside daily aspirin as part of the treatment plan set by the doctor. Your doctor will decide if it is suitable for you.
Ticaflow 90 কীভাবে ব্যবহার করবেন
Swallow the tablet as directed. Swallow the tablet with water. Ticaflow 90 is taken by mouth. Take Ticaflow 90 tablet exactly as your doctor tells you. Do not stop or change the medicine on your own, because stopping can raise the risk of heart attack, stent thrombosis and death. Complete the course exactly as prescribed.
Ticaflow 90-এর পার্শ্বপ্রতিক্রিয়া
Common side effects that have been reported with Ticagrelor include shortness of breath, bleeding, headache, cough, dizziness, nausea, diarrhoea, back pain, fatigue, chest pain, low blood pressure, high blood pressure and atrial fibrillation. The doctor can advise whether you need review or a change in treatment. Because it affects platelets, bleeding is a particular concern. Tell your doctor if any side effect bothers you or does not go away. Contact your doctor if you notice anything unusual after taking it.
সতর্কতা ও নিরাপত্তা
It is not for people with moderate to severe liver problems or with allergies to the ingredients. Always tell the doctor and pharmacist about all medicines you take, and ask them first before starting or stopping anything. Ticaflow 90 increases the risk of bleeding, so tell the doctor about any bleeding problem, peptic ulcer or past bleeding in the brain.
সাধারণ প্রশ্ন
What is Ticaflow 90 used for?
Ticaflow 90 is used in adults to help prevent atherothrombotic events after an acute coronary syndrome. It is prescribed whether the patient is managed with medicines alone or with procedures such as percutaneous coronary intervention or coronary artery bypass grafting.
How do I use Ticaflow 90 correctly?
Swallow the tablet as directed. Swallow the tablet with water.
What are the side effects of Ticaflow 90?
Common side effects that have been reported with Ticagrelor include shortness of breath, bleeding, headache, cough, dizziness, nausea, diarrhoea, back pain, fatigue, chest pain, low blood pressure, high blood pressure and atrial fibrillation. The doctor can advise whether you need review or a change in treatment.
Can I use Ticaflow 90 in pregnancy or while breastfeeding?
It is not for people with moderate to severe liver problems or with allergies to the ingredients. Always tell the doctor and pharmacist about all medicines you take, and ask them first before starting or stopping anything.
নির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Ticagrelor is indicated for the prevention of atherothrombotic events in adult patients with Acute Coronary Syndromes (unstable angina, non ST elevation Myocardial Infarction [NSTEMI] or ST elevation Myocardial Infarction [STEMI]); including patients managed medically, and those who are managed with percutaneous coronary intervention (PCI) or coronary artery by-pass grafting (CABG).ফার্মাকোলজি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Ticagrelor is a selective adenosine diphosphate (ADP) receptor antagonist acting on the P2Y12 ADP-receptor that can prevent ADP-mediated platelet activation and aggregation. Ticagrelor reversibly interacts with the platelet P2Y12 ADP-receptor.Ticagrelor does not interact with the ADP binding site itself, but interacts with platelet P2Y12 ADP-receptor to prevent signal transduction.Thus it prevents platelet activation & aggregation.মাত্রা ও সেবনবিধি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Ticagrelor treatment should be initiated with a single 180 mg loading dose (two tablets of 90 mg) and then continued at 90 mg twice daily. Patients taking Ticagrelor should also take aspirin daily, unless specifically contraindicated. Following an initial dose of aspirin (usually 325 mg), Ticagrelor should be used with a maintenance dose of aspirin of 75-100 mg. Maintenance dose of Aspirin above 100 mg decreased the efficacy of Ticagrelor. So, maintenance dose of aspirin above 100 mg should be avoided.A patient who misses a dose of Ticagrelor should take only one 90 mg tablet (the next dose) at its scheduled time. Patients treated with Clopidogrel can be directly switched to Ticagrelor if needed. Switching from prasugrel to ticagrelor has not been investigated.
Treatment is recommended for up to 12 months unless discontinuation of Ticagrelor is clinically indicated. Ticagrelor can be administered with or without food.
ঔষধের মিথষ্ক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
CYP3A inhibitors: Avoid use of strong inhibitors of CYP3A (e.g., ketoconazole, itraconazole, voriconazole, clarithromycin, nefazodone, ritonavir, saquinavir, nelfinavir, indinavir, atazanavir and telithromycin).CYP3A inducers: Avoid use with potent inducers of CYP3A (e.g., rifampin, dexamethasone, phenytoin,carbamazepine and phenobarbital).
Aspirin: Use of Ticagrelor with aspirin maintenance doses above 100 mg reduced the effectiveness ofTicagrelor.
Simvastatin, Lovastatin: Ticagrelor will result in higher serum concentrations of simvastatin and lovastatin because these drugs are metabolized by CYP3A4. Avoid simvastatin and lovastatin doses greater than 40 mg.
Digoxin: Because of inhibition of the P-glycoprotein transporter, monitor digoxin levels with initiation of or any change in ticagrelor therapy.
Other Concomitant Therapy: Ticagrelor can be administered with unfractionated or low-molecular-weight heparin, GPIIb/llla inhibitors, proton pump inhibitors, beta-blockers, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers.
প্রতিনির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Ticagrelor is contraindicated in case of-- Hypersensitivity to Ticagrelor or to any of the excipients
- Active pathological bleeding (peptic ulcer)
- History of intracranial haemorrhage
- Moderate to severe hepatic impairment
- Co-administration of Ticagrelor with strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin, nefazodone, ritonavir, and atazanavir)
পার্শ্ব প্রতিক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Dyspnea,bleeding,headache,cough,dizziness,nausea,atrial fibrillation, hypertension, non-cardiac chest pain, diarrhea, back pain, hypotension, fatigue, chest pain.গর্ভাবস্থায় ও স্তন্যদানকালে
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pregnancy category C. There are no or limited amount of data from the use of Ticagrelor in pregnant women.Ticagrelor is not recommended during pregnancy.Nursing mothers: Available pharmacodynamic/toxicological data in animals have shown excretion of Ticagrelor and its active metabolites in milk. A risk to newborns/infants cannot be excluded. A decision must be made whether to discontinue breastfeeding or to discontinue/abstain from ticagrelor therapy taking into account the benefit of breastfeeding for the child and the benefit of therapy for the women.
সতর্কতা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
General Risk of Bleeding: Drugs that inhibit platelet function including Ticagrelor increase the risk of bleeding.Concomitant Aspirin Maintenance Dose: Use of Ticagrelor with maintenance doses of aspirin above 100 mg decreased the effectiveness of Ticagrelor. Therefore, after the initial loading dose of aspirin (usually 325 mg), use Ticagrelor with a maintenance dose of aspirin of 75-100 mg.
Moderate Hepatic Impairment: Ticagrelor has not been studied in patients with moderate hepatic impairment.
Discontinuation of Ticagrelor: Discontinuation of Ticagrelor will increase the risk of myocardial infarction, stent thrombosis, and death.
মাত্রাধিক্যতা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
There is currently no known antidote to reverse the effects ofTicagrelor and it is not expected to be dialysable.Treatment of overdose should follow local standard medical practice.The expected effect of excessive ticagrelor dosing is prolonged duration of bleeding risk associated with platelet inhibition. If bleeding occurs appropriate supportive measures should be taken.সংরক্ষণ
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Protect from light & moisture. Store below 25° C. Keep out of reach of children.বিকল্প ব্র্যান্ড: Ticagrelor
একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।